Pharmaceutical companies are increasingly partnering with social media influencers to market prescription medications, a practice that researchers say poses significant public health risks. The warning comes from a study published in JAMA Network Open, a peer-reviewed journal, which examined the growing intersection of influencer marketing and prescription drug promotion.

The influencer marketing industry is projected to surpass $32 billion globally, and pharmaceutical marketing teams have taken notice, regularly enlisting influencers with audiences ranging from hundreds of thousands to millions of followers to promote their products — including drugs that require a physician's prescription.

Researchers flagged concerns that such promotional content may bypass the traditional safeguards associated with prescription drug advertising, potentially encouraging consumers to seek medications without adequate medical guidance, misrepresent risks and benefits, or create demand for drugs that may not be appropriate for a given individual's health profile.

IMPORTANT EDITORIAL NOTES: The full text of the JAMA Network Open study was not directly reviewed for this article. Study design (RCT vs. observational), sample size, authorship, and potential conflicts of interest could not be independently verified from the available source summary. Readers are advised to consult the primary JAMA Network Open publication for complete methodological details. Source: https://medicalxpress.com/news/2026-03-prescription-drugs-social-media-pose.html